. 2017 Apr 18;15(2):83–93. doi: 10.1016/j.aju.2017.03.005

Table 1.

Demographics of the 10 included studies.

Reference	Power calculation	Treatment vs control	Age, years, mean (SD) or median (IQR)	Gender, M:F, n	Stone location and size, mm	Stone size, mm, mean (SD) or median (IQR)
Al-Ansari et al. [25]	Yes	Tamsulosin	37.18 (9.38)	32:18	Distal ureter	5.88 (2.39)
Al-Ansari et al. [25]		Control	36.13 (9.32)	35:15	<10	6.04 (2.5)
Furyk et al. [26]	Yes	Tamsulosin	45.5 (35–55)	156:42	Distal ureter	n/a
Furyk et al. [26]		Control	46 (37–55)	164:31	<10
Hermanns et al. [27]	Yes	Tamsulosin	36 (30–44)	39:6	Distal ureter	4.1 (3.5–4.9)
Hermanns et al. [27]		Placebo	41 (33–54)	36:9	<7	3.8 (3.4–4.3)
Ochoa-Gomez et al. [28]	Yes	Tamsulosin	38.5 (11.3)	15:17	Distal ureter	5.3 (0.55)
Ochoa-Gomez et al. [28]		Control	38.2 (12.4)	21:12	<10	5.2 (0.39)
Pedro et al. [29]	Yes	Alfuzosin	36.69 (13.06)	28: 6	Distal ureter	3.83 (0.94)
Pedro et al. [29]		Control	42.03 (12.85)	27: 8	<8	4.07 (1.13)
Pickard et al. [30]	Yes	Tamsulosin	43.1 (11.5)	310:68	Pan ureter	4.6 (1.6)
		Nifedipine	42.3 (11.0)	313:66	<10	4.5 (1.6)
		Control	42.8 (12.3)	294:85		4.5 (1.7)
Sameer et al. [31]	Yes	Alfuzosin	30.82 (7.85)	26:9	Distal ureter	6.26 (1.85)
		Nifedipine	32.74 (9.58)	19:16	<10	6.5 (1.78)
		Control	33.06 (8.76)	23:12		6.37 (1.85)
Sur et al. [32]	Yes	Silodosin	47 (13)	72:42	Pan-ureter	5.4 (1.4)
Sur et al. [32]		Control	47 (15)	80:38	4–10	5.5 (1.6)
Vincendeau et al. [33]	Yes	Tamsulosin	38.9 (13.4)	43:18	Distal ureter	2.9 (1)
Vincendeau et al. [33]		Placebo	39.0 (11.4)	52:9	2–7	3.2 (1.2)
Wang et al. [34]	Yes	Silodosin	51.42 (8.68)	40:22	Distal ureter	6.47 (1.39)
Wang et al. [34]		Placebo	51.51 (10.03)	43:18	4–10	6.46 (1.31)

IQR, interquartile range; n/a, not available.